Skip to content
Guavy Logo GUAVY
Sign up
Back to Guavy Wire
Stocks

DeepScribe Targets Oncology Workflows with Ambient AI Strategy

Guavy AI Editorial Team
Instruments
MRK
Share

A recent LinkedIn post by DeepScribe highlights the challenges in precision oncology workflows due to rapid advances in treatment coordination.

The post references Phase 3 results for an mRNA melanoma vaccine from Merck and Moderna used with Keytruda, and daraxonrasib's survival benefits in metastatic pancreatic cancer, as examples of a fast-evolving therapeutic landscape.

According to CEO Matthew Ko, 'ambient AI' can serve as coordination infrastructure at the point of treatment planning, indicating DeepScribe's strategic focus on clinical workflow integration rather than drug development.

More on Stocks

Stocks 8m ago

Dow Jones Futures Tumble Under Pressure from Surging Yields and $100 Oil

Stocks 13m ago

AbbVie Stock Traded at 71.5 PE Ratio Raises Valuation Concerns

Stocks 17m ago

Canada's AI Agent Market Explodes with 26x Pricing Gap

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Guavy Logo GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

© 2026 Guavy Inc

Terms Privacy Policy